Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Local Anesthetics: Differential Sensitivity of Nerve Fibers01:24

Local Anesthetics: Differential Sensitivity of Nerve Fibers

1.7K
Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
1.7K
Analgesia and Pain Management01:25

Analgesia and Pain Management

3.2K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.2K
Nociception01:44

Nociception

35.0K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
35.0K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

785
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
785

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-Vesicular Release of Alarmin Prothymosin α Complex Associated with Annexin-2 Flop-Out.

Cells·2023
Same author

Development of green fluorescent protein-based cAMP indicators for covering a wide range of cAMP concentrations.

RSC advances·2023
Same author

A Real-Time Learning Analytics Dashboard for Automatic Detection of Online Learners' Affective States.

Sensors (Basel, Switzerland)·2023
Same author

Formation of Hemihydrate Crystal form Overcomes Milling Issue Induced by Exposed Functional Groups on Cleavage Plane for a Y5 Receptor Antagonist of Neuropeptide Y.

Journal of pharmaceutical sciences·2023
Same author

Efficient Microfluidic Screening Method Using a Fluorescent Immunosensor for Recombinant Protein Secretions.

Small (Weinheim an der Bergstrasse, Germany)·2023
Same author

Generation of Q-bead against bone Gla protein with simplified preparation steps.

Journal of immunological methods·2023

Related Experiment Video

Updated: Apr 17, 2026

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

49.8K

Minocycline Does Not Decrease Intensity of Neuropathic Pain Intensity, But Does Improve Its Affective Dimension.

Masahiko Sumitani, Hiroshi Ueda, Jun Hozumi

    Journal of Pain & Palliative Care Pharmacotherapy
    |February 21, 2015
    PubMed
    Summary

    Minocycline did not reduce neuropathic pain intensity in patients. However, this antibiotic effectively lessened the emotional component of pain, suggesting a role in managing the affective dimension of neuropathic pain.

    Keywords:
    SF-MPQmicrogliaminocyclineneuropathic pain

    More Related Videos

    Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
    08:16

    Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

    Published on: October 6, 2022

    8.4K
    Modified Spared Nerve Injury Surgery Model of Neuropathic Pain in Mice
    04:34

    Modified Spared Nerve Injury Surgery Model of Neuropathic Pain in Mice

    Published on: January 25, 2022

    7.6K

    Related Experiment Videos

    Last Updated: Apr 17, 2026

    The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
    07:09

    The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

    Published on: July 16, 2014

    49.8K
    Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
    08:16

    Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

    Published on: October 6, 2022

    8.4K
    Modified Spared Nerve Injury Surgery Model of Neuropathic Pain in Mice
    04:34

    Modified Spared Nerve Injury Surgery Model of Neuropathic Pain in Mice

    Published on: January 25, 2022

    7.6K

    Area of Science:

    • Neuroscience
    • Pharmacology
    • Pain Management

    Background:

    • Microglia play a key role in the development of neuropathic pain.
    • Minocycline, an antibiotic, shows promise for treating neuropathic pain, but its clinical efficacy is not well-established.

    Purpose of the Study:

    • To evaluate the clinical effectiveness of minocycline as an adjunct therapy for neuropathic pain.

    Main Methods:

    • An open-label study involving 20 patients with neuropathic pain.
    • Minocycline was administered at 100 mg/day for 1 week, then 200 mg/day for 3 weeks.
    • Pain severity was assessed using the Numerical Rating Scale (NRS) and the Short-Form McGill Pain Questionnaire (SF-MPQ).

    Main Results:

    • Minocycline was generally well-tolerated.
    • No significant reduction in pain intensity was observed on the NRS.
    • A significant decrease in the total SF-MPQ score was noted, driven by a reduction in the affective subscale, not the sensory subscale.

    Conclusions:

    • Minocycline did not improve overall pain intensity in patients with neuropathic pain.
    • Minocycline effectively reduced the affective (emotional) component of neuropathic pain.
    • Further research is warranted to explore minocycline's role in managing the emotional aspects of chronic pain conditions.